CoChat

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies

Open access
Infantino, Maria, Meacci, Francesca, Bentow, Chelsea, Martis, Peter, Benucci, Maurizio, Afeltra, Antonella, Rigon, Amelia, Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Manfredi, Mariangela, Mahler, Michael · 2015 · Journal of Immunology Research

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Introduction . The objective of the present study was to compare QUANTA Flash dsDNA, a chemiluminescent immunoassay (CIA) on the BIO-FLASH, a rapid-response chemiluminescent analyzer, to three other anti-dsDNA antibody assays and to Crithidia luciliae indirect immunofluorescence test (CLIFT). Methods . In the first part of the study, 161 samples, 61 from patients suffering from systemic lupus erythematosus (SLE) and 100 from a disease control group, were tested by QUANTA Flash dsDNA CIA, QUANTA Lite dsDNA SC ELISA, BioPlex 2200 multiplex flow immunoassay (MFI), ImmuLisa dsDNA ELISA, and NOVA Lite CLIFT. A second cohort of 69 SLE patients was then tested by QUANTA Flash dsDNA and CLIFT to expand the study. Results . The overall qualitative agreements varied between 77.0% (NOVA Lite CLIFT versus QUANTA Lite) and 89.4% (ImmuLisa versus NOVA Lite CLIFT). The clinical sensitivities for the anti-dsDNA antibody tests varied from 8.2% (NOVA Lite CLIFT) to 54.1% (QUANTA Lite), while the clinical specificities varied from 88.0% (BioPlex 2200) to 100.0% (NOVA Lite CLIFT). Good correlation was found between QUANTA Flash dsDNA and NOVA Lite CLIFT. Conclusion . Significant variations among dsDNA methods were observed. QUANTA Flash dsDNA provides a good combination of sensitivity and specificity for the diagnosis of SLE and good agreement to CLIFT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/902821

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Comparison of different assays for the detection of anti-dsDNA antibodies using receiver operating characteristics (ROC) analysis. The ROC curves show the discrimination between SLE patients (n = 61) and controls (n = 100) using different assays. Note: the NOVA Lite CLIFT assay is a semiquantitative assay (grades 0 to 4 were given by operator).
Figure 1 Comparison of different assays for the detection of anti-dsDNA antibodies using receiver operating characteristics (ROC) analysis. The ROC curves show the discrimination between SLE patients (n = 61) and controls (n = 100) using different assays. Note: the NOVA Lite CLIFT assay is a semiquantitative assay (grades 0 to 4 were given by operator).CC BY · PubMed Central
Figure 2 Supervised cluster analysis of the results. Supervised centered cluster analysis according to disease cohort (SLE versus controls) is shown. The dendrogram shows the QUANTA Lite dsDNA SC clusters closest to the diagnosis of SLE followed by QUANTA Flash and BioPlex 2200. SLE: systemic lupus erythematosus.
Figure 2 Supervised cluster analysis of the results. Supervised centered cluster analysis according to disease cohort (SLE versus controls) is shown. The dendrogram shows the QUANTA Lite dsDNA SC clusters closest to the diagnosis of SLE followed by QUANTA Flash and BioPlex 2200. SLE: systemic lupus erythematosus.CC BY · PubMed Central
Figure 3 Comparison of NOVA Lite CLIFT and QUANTA Flash dsDNA for the detection of anti-dsDNA antibodies using receiver operating characteristics (ROC) analysis. The ROC curves show the discrimination between SLE patients (n = 130) and controls (n = 100). Note: the NOVA Lite CLIFT is a semiquantitative assay (grades 0 to 4 were given by operator).
Figure 3 Comparison of NOVA Lite CLIFT and QUANTA Flash dsDNA for the detection of anti-dsDNA antibodies using receiver operating characteristics (ROC) analysis. The ROC curves show the discrimination between SLE patients (n = 130) and controls (n = 100). Note: the NOVA Lite CLIFT is a semiquantitative assay (grades 0 to 4 were given by operator).CC BY · PubMed Central
Figure 4 Receiver operating characteristics (ROC) analysis of QUANTA Flash dsDNA compared to CLIFT positive (n = 35) and negative (n = 195) samples. Different cut-offs are shown to demonstrate the optimal agreements. Note: equivocal range determined by the manufacturer is along the 80.0% positive agreement (green highlight). PPA: positive percent agreement; TPA: total percent agreement.
Figure 4 Receiver operating characteristics (ROC) analysis of QUANTA Flash dsDNA compared to CLIFT positive (n = 35) and negative (n = 195) samples. Different cut-offs are shown to demonstrate the optimal agreements. Note: equivocal range determined by the manufacturer is along the 80.0% positive agreement (green highlight). PPA: positive percent agreement; TPA: total percent agreement.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. 2014, Journal of the Medical Association of Thailand: Chotmaihet thangphaet, 97, 220

Cited by

See all 41

Metadata

Authors
Infantino, M., Meacci, F., Bentow, C., Martis, P., Benucci, M., Afeltra, A., Rigon, A., Atzeni, F., Sarzi-Puttini, P., Manfredi, M., & Mahler, M.
Affiliations
  • Nuovo Ospedale San Giovanni di Dio (IT)
  • Inova Diagnostics, Inc., San Diego, CA 92131, USA
  • Università Campus Bio-Medico (IT)
  • Luigi Sacco Hospital (IT)
  • UOC Reumatologia, Ospedale L. Sacco Polo Universitario, Via Giovanni Battista Grassi 74, 20157 Milano, Italy
Corresponding author
Infantino, Maria
Venue
Journal of Immunology Research
Publisher
Wiley
Published
2015
Volume
2015
Pages
1-8
ISSN
  • 2314-7156 (ISSN-L)
  • 2314-8861
OpenAlex
W1991963925
Cited by
41
References
23
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 8 · 2020: 1 · 2018: 4 · 2017: 7 · 2016: 5 · 2015: 1
FWCI
4.75
Type
journal article
Language
en
Open access
Locations
  • Journal of Immunology Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords
anti-dsDNA antibodies, chemiluminescence immunoassay, systemic lupus erythematosus, ELISA, sensitivity and specificity, assay agreement
MeSH terms
Antibodies, Antinuclear, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, ROC Curve, Sensitivity and Specificity, Reproducibility of Results, Cluster Analysis, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.